 Connection
Charles Daley to Mice
This is a "connection" page, showing publications Charles Daley has written about Mice.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.075 |
|
|
|
-
Daley CL. Update in tuberculosis 2009. Am J Respir Crit Care Med. 2010 Mar 15; 181(6):550-5.
Score: 0.023
-
Nguyen MH, Plattner M, Verma D, Krishnamurthy RV, Xie M, Calado Nogueira de Moura V, Haldimann K, Lang R, Becker K, Kaur P, Shandil RK, Singh M, Bulman ZP, Dick T, Narayanan S, Schulthess B, Mitarai S, Daley CL, Hobbie SN. Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteria. EBioMedicine. 2026 Jan; 123:106103.
Score: 0.017
-
Dartois V, Bonfield TL, Boyce JP, Daley CL, Dick T, Gonzalez-Juarrero M, Gupta S, Kramnik I, Lamichhane G, Laughon BE, Lorè NI, Malcolm KC, Olivier KN, Tuggle KL, Jackson M. Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations. Tuberculosis (Edinb). 2024 07; 147:102503.
Score: 0.015
-
Gonzalez-Juarrero M, Lukka PB, Wagh S, Walz A, Arab J, Pearce C, Ali Z, Ryman JT, Parmar K, Temrikar Z, Munoz-Gutierrez J, Robertson GT, Liu J, Lenaerts AJ, Daley C, Lee RE, Braunstein M, Hickey AJ, Meibohm B. Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis. ACS Infect Dis. 2021 10 08; 7(10):2850-2863.
Score: 0.013
-
Choi GE, Shin SJ, Won CJ, Min KN, Oh T, Hahn MY, Lee K, Lee SH, Daley CL, Kim S, Jeong BH, Jeon K, Koh WJ. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med. 2012 Nov 01; 186(9):917-25.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|